Robert Saklatvala

532 total citations
15 papers, 421 citations indexed

About

Robert Saklatvala is a scholar working on Pharmaceutical Science, Materials Chemistry and Immunology. According to data from OpenAlex, Robert Saklatvala has authored 15 papers receiving a total of 421 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmaceutical Science, 5 papers in Materials Chemistry and 3 papers in Immunology. Recurrent topics in Robert Saklatvala's work include Crystallization and Solubility Studies (4 papers), Thermal and Kinetic Analysis (3 papers) and Drug Solubulity and Delivery Systems (3 papers). Robert Saklatvala is often cited by papers focused on Crystallization and Solubility Studies (4 papers), Thermal and Kinetic Analysis (3 papers) and Drug Solubulity and Delivery Systems (3 papers). Robert Saklatvala collaborates with scholars based in United Kingdom, United States and China. Robert Saklatvala's co-authors include Duncan Q.M. Craig, Graham Buckton, Caroline McGregor, Sheng Qi, Catherine Tuleu, Michael Newton, Steven W. Booth, Jun Xu, Paul G. Royall and Adam Procopio and has published in prestigious journals such as Journal of Controlled Release, Journal of Chromatography A and International Journal of Pharmaceutics.

In The Last Decade

Robert Saklatvala

14 papers receiving 397 citations

Peers

Robert Saklatvala
M.L. Vueba Portugal
Michael Lowinger United States
Diana M. Sperger United States
Robert Saklatvala
Citations per year, relative to Robert Saklatvala Robert Saklatvala (= 1×) peers Maciej Gajda

Countries citing papers authored by Robert Saklatvala

Since Specialization
Citations

This map shows the geographic impact of Robert Saklatvala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Saklatvala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Saklatvala more than expected).

Fields of papers citing papers by Robert Saklatvala

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Saklatvala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Saklatvala. The network helps show where Robert Saklatvala may publish in the future.

Co-authorship network of co-authors of Robert Saklatvala

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Saklatvala. A scholar is included among the top collaborators of Robert Saklatvala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Saklatvala. Robert Saklatvala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Yadav, Vipul, Laura E. McCoubrey, Peter W. Fan, et al.. (2022). Ileocolonic-Targeted JAK Inhibitor: A Safer and More Effective Treatment for Inflammatory Bowel Disease. Pharmaceutics. 14(11). 2385–2385. 13 indexed citations
2.
Gomaa, Yasmine, et al.. (2021). Development of a thermostable oxytocin microneedle patch. Journal of Controlled Release. 337. 81–89. 18 indexed citations
3.
Xu, Jun, Nicolas Solban, Yun Wang, et al.. (2021). Sonoporation‐Enhanced Delivery of STING Agonist Induced Robust Immune Modulation and Tumor Regression (Adv. Therap. 10/2021). Advanced Therapeutics. 4(10). 1 indexed citations
4.
Xu, Jun, Nicolas Solban, Yun Wang, et al.. (2021). Sonoporation‐Enhanced Delivery of STING Agonist Induced Robust Immune Modulation and Tumor Regression. Advanced Therapeutics. 4(10). 4 indexed citations
5.
Xu, Jun, et al.. (2020). Recent Progress of Potentiating Immune Checkpoint Blockade with External Stimuli—an Industry Perspective. Advanced Science. 7(8). 1903394–1903394. 46 indexed citations
6.
Dutta, Kingshuk, Ritam Das, Rafael Mayoral, et al.. (2020). In Situ Forming Injectable Thermoresponsive Hydrogels for Controlled Delivery of Biomacromolecules. ACS Omega. 5(28). 17531–17542. 57 indexed citations
7.
Milewski, Mikolaj, et al.. (2016). Rapid Absorption of Dry-Powder Intranasal Oxytocin. Pharmaceutical Research. 33(8). 1936–1944. 15 indexed citations
8.
Qi, Sheng, et al.. (2007). An investigation into the effects of thermal history on the crystallisation behaviour of amorphous paracetamol. European Journal of Pharmaceutics and Biopharmaceutics. 69(1). 364–371. 63 indexed citations
10.
McGregor, Caroline, et al.. (2004). The use of high-speed differential scanning calorimetry (Hyper-DSC™) to study the thermal properties of carbamazepine polymorphs. Thermochimica Acta. 417(2). 231–237. 64 indexed citations
12.
Fitzpatrick, Shaun & Robert Saklatvala. (2003). Understanding the Physical Stability of Freeze Dried Dosage Forms rom the Glass Transition Temperature of the Amorphous Components. Journal of Pharmaceutical Sciences. 92(12). 2495–2501. 9 indexed citations
13.
Saklatvala, Robert, et al.. (2000). The preparation and evaluation of progesterone-loaded poly(d, 1-lactide) microspheres. UCL Discovery (University College London). 1 indexed citations
14.
Saklatvala, Robert, Paul G. Royall, & Duncan Q.M. Craig. (1999). The detection of amorphous material in a nominally crystalline drug using modulated temperature DSC—a case study. International Journal of Pharmaceutics. 192(1). 55–62. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026